107 related articles for article (PubMed ID: 17651538)
41. A phase II study of oxaliplatin, dose-intense capecitabine, and high-dose bevacizumab in the treatment of metastatic colorectal cancer.
Wong NS; Fernando NH; Bendell JC; Morse MA; Blobe GC; Honeycutt W; Pang H; Hurwitz HI
Clin Colorectal Cancer; 2011 Sep; 10(3):210-6. PubMed ID: 21855046
[TBL] [Abstract][Full Text] [Related]
42. Capecitabine plus oxaliplatin vs fluorouracil plus oxaliplatin as first line treatment for metastatic colorectal caner - meta-analysis of six randomized trials.
Cao Y; Liao C; Tan A; Liu L; Mo Z; Gao F
Colorectal Dis; 2010 Jan; 12(1):16-23. PubMed ID: 19220378
[TBL] [Abstract][Full Text] [Related]
43. Phase II trial of erlotinib plus capecitabine as first-line treatment for metastatic pancreatic cancer (XELTA study).
López R; Méndez CM; Fernández MJ; Reinoso CR; Aldana GQ; Fernández MS; DE LA Cámara Gómez J; López MR; Vázquez MR; Folgar SC
Anticancer Res; 2013 Feb; 33(2):717-23. PubMed ID: 23393373
[TBL] [Abstract][Full Text] [Related]
44. Phase II trial of erlotinib and capecitabine for patients with previously untreated metastatic colorectal cancer.
Kozuch P; Malamud S; Wasserman C; Homel P; Mirzoyev T; Grossbard M
Clin Colorectal Cancer; 2009 Jan; 8(1):38-42. PubMed ID: 19203895
[TBL] [Abstract][Full Text] [Related]
45. Capecitabine and oxaliplatin in advanced colorectal cancer: a dose-finding study.
Zeuli M; Di Costanzo E; Sdrobolini A; Gasperoni S; Paoloni FP; Carpi A; Moscetti L; Cherubini R; Cognetti F; ;
Ann Oncol; 2001 Dec; 12(12):1737-41. PubMed ID: 11843252
[TBL] [Abstract][Full Text] [Related]
46. Oxaliplatin and capecitabine chemotherapy for advanced colorectal cancer: a single institution's experience.
Sumpter K; Harper-Wynne C; Cunningham D; Gillbanks A; Norman AR; Hill M
Clin Oncol (R Coll Radiol); 2003 Aug; 15(5):221-6. PubMed ID: 12924449
[TBL] [Abstract][Full Text] [Related]
47. Sequential versus combination chemotherapy with capecitabine, irinotecan, and oxaliplatin in advanced colorectal cancer (CAIRO): a phase III randomised controlled trial.
Koopman M; Antonini NF; Douma J; Wals J; Honkoop AH; Erdkamp FL; de Jong RS; Rodenburg CJ; Vreugdenhil G; Loosveld OJ; van Bochove A; Sinnige HA; Creemers GM; Tesselaar ME; Slee PHTJ; Werter MJ; Mol L; Dalesio O; Punt CJ
Lancet; 2007 Jul; 370(9582):135-142. PubMed ID: 17630036
[TBL] [Abstract][Full Text] [Related]
48. A phase II study of gefitinib, 5-fluorouracil, leucovorin, and oxaliplatin in previously untreated patients with metastatic colorectal cancer.
Fisher GA; Kuo T; Ramsey M; Schwartz E; Rouse RV; Cho CD; Halsey J; Sikic BI
Clin Cancer Res; 2008 Nov; 14(21):7074-9. PubMed ID: 18981005
[TBL] [Abstract][Full Text] [Related]
49. Phase I/II study of gefitinib and capecitabine in patients with colorectal cancer.
Jimeno A; Grávalos C; Escudero P; Sevilla I; Vega-Villegas ME; Alonso V; Juez I; García-Carbonero R; Bovio H; Colomer R; Cortés-Funes H
Clin Transl Oncol; 2008 Jan; 10(1):52-7. PubMed ID: 18208793
[TBL] [Abstract][Full Text] [Related]
50. Short-time infusion of oxaliplatin (Eloxatin) in combination with capecitabine (Xeloda) in patients with advanced colorectal cancer.
Pfeiffer P; Hahn P; Jensen HA
Acta Oncol; 2003; 42(8):832-6. PubMed ID: 14968944
[TBL] [Abstract][Full Text] [Related]
51. Heated (37 degrees C) oxaliplatin infusion in combination with capecitabine for metastatic colorectal carcinoma: can it reduce neuropathy?
Cathomas R; Köberle D; Ruhstaller T; Mayer G; Räss A; Mey U; von Moos R
Support Care Cancer; 2010 Oct; 18(10):1263-70. PubMed ID: 19756772
[TBL] [Abstract][Full Text] [Related]
52. Phase I/II trial of gefitinib and oxaliplatin in patients with advanced colorectal cancer.
Kindler HL; Friberg G; Skoog L; Wade-Oliver K; Vokes EE
Am J Clin Oncol; 2005 Aug; 28(4):340-4. PubMed ID: 16062074
[TBL] [Abstract][Full Text] [Related]
53. Combined treatment of oxaliplatin and capecitabine in patients with metastatic esophageal squamous cell cancer.
Qin TJ; An GL; Zhao XH; Tian F; Li XH; Lian JW; Pan BR; Gu SZ
World J Gastroenterol; 2009 Feb; 15(7):871-6. PubMed ID: 19230050
[TBL] [Abstract][Full Text] [Related]
54. Phase I study of gefitinib, oxaliplatin, 5-fluorouracil, and leucovorin (IFOX) in patients with advanced solid malignancies.
Cho CD; Fisher GA; Halsey J; Sikic BI
Invest New Drugs; 2006 Mar; 24(2):117-23. PubMed ID: 16683204
[TBL] [Abstract][Full Text] [Related]
55. Capecitabine plus oxaliplatin in metastatic colorectal cancer.
Cassidy J
J Clin Oncol; 2007 Nov; 25(31):5043-5; author reply 5045-6. PubMed ID: 17971611
[No Abstract] [Full Text] [Related]
56. A phase I/II study of trimetrexate and capecitabine in patients with advanced refractory colorectal cancer.
Matin K; Jacobs SA; Richards T; Wong MK; Earle M; Evans T; Troetschel M; Ferri W; Friedland D; Pinkerton R; Volkin R; Wieand S; Ramanathan RK
Am J Clin Oncol; 2005 Oct; 28(5):439-44. PubMed ID: 16199980
[TBL] [Abstract][Full Text] [Related]
57. A phase I study of gefitinib, capecitabine, and celecoxib in patients with advanced solid tumors.
Lam ET; O'Bryant CL; Basche M; Gustafson DL; Serkova N; Baron A; Holden SN; Dancey J; Eckhardt SG; Gore L
Mol Cancer Ther; 2008 Dec; 7(12):3685-94. PubMed ID: 19074845
[TBL] [Abstract][Full Text] [Related]
58. Comments on final report of the AIO Colorectal Cancer Group Study: fluorouracil/oxaliplatin versus capecitabine/oxaliplatin.
Buechele T
J Clin Oncol; 2007 Nov; 25(31):5041-2; author reply 5042-3. PubMed ID: 17971610
[No Abstract] [Full Text] [Related]
59. A phase II study of capecitabine plus oxaliplatin (XELOX): a new first-line option in metastatic colorectal cancer.
Makatsoris T; Kalofonos HP; Aravantinos G; Papadimitriou C; Kastritis E; Rigatos SK; Xiros N; Petsas T; Economopoulos T; Sakadamis AK; Fountzilas G;
Int J Gastrointest Cancer; 2005; 35(2):103-9. PubMed ID: 15879624
[TBL] [Abstract][Full Text] [Related]
60. Pulmonary toxicity with oxaliplatin and capecitabine/5-Fluorouracil chemotherapy: a case report and review of the literature.
Chan AK; Choo BA; Glaholm J
Onkologie; 2011; 34(8-9):443-6. PubMed ID: 21934344
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
